318 related articles for article (PubMed ID: 17360334)
1. A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
Phillips JD; Bergonia HA; Reilly CA; Franklin MR; Kushner JP
Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5079-84. PubMed ID: 17360334
[TBL] [Abstract][Full Text] [Related]
2. A mouse model of familial porphyria cutanea tarda.
Phillips JD; Jackson LK; Bunting M; Franklin MR; Thomas KR; Levy JE; Andrews NC; Kushner JP
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):259-64. PubMed ID: 11134514
[TBL] [Abstract][Full Text] [Related]
3. Uroporphyria in the uroporphyrinogen decarboxylase-deficient mouse: Interplay with siderosis and polychlorinated biphenyl exposure.
Franklin MR; Phillips JD; Kushner JP
Hepatology; 2002 Oct; 36(4 Pt 1):805-11. PubMed ID: 12297827
[TBL] [Abstract][Full Text] [Related]
4. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda.
Franklin MR; Phillips JD; Kushner JP
Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724
[TBL] [Abstract][Full Text] [Related]
6. Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Sinclair JF; Gerhard GS; Szakacs JG; Andrews NC; Levy JE
Hepatology; 2001 Feb; 33(2):406-12. PubMed ID: 11172342
[TBL] [Abstract][Full Text] [Related]
7. Levels of uroporphyrinogen decarboxylase (URO-D) in erythrocytes of Italian porphyria cutanea tarda patients.
Tavazzi D; Martinez di Montemuros F; Fargion S; Fracanzani AL; Fiorelli G; Cappellini MD
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):27-32. PubMed ID: 11929044
[TBL] [Abstract][Full Text] [Related]
8. Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda.
Garey JR; Franklin KF; Brown DA; Harrison LM; Metcalf KM; Kushner JP
Gastroenterology; 1993 Jul; 105(1):165-9. PubMed ID: 8099886
[TBL] [Abstract][Full Text] [Related]
9. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
[TBL] [Abstract][Full Text] [Related]
10. Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases.
Warby CA; Phillips JD; Bergonia HA; Whitby FG; Hill CP; Kushner JP
Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):40-5. PubMed ID: 19656450
[TBL] [Abstract][Full Text] [Related]
11. Porphyria cutanea tarda.
Fritsch C; Lang K; von Schmiedeberg S; Bolsen K; Merk H; Lehmann P; Ruzicka T
Skin Pharmacol Appl Skin Physiol; 1998; 11(6):321-35. PubMed ID: 10343203
[TBL] [Abstract][Full Text] [Related]
12. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.
Mendez M; Sorkin L; Rossetti MV; Astrin KH; del C Batlle AM; Parera VE; Aizencang G; Desnick RJ
Am J Hum Genet; 1998 Nov; 63(5):1363-75. PubMed ID: 9792863
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of uroporphyrin does not provoke further inhibition of liver uroporphyrinogen decarboxylase activity in hexachlorobenzene-induced porphyria.
Adjarov DG; Elder GH
IARC Sci Publ; 1986; (77):467-9. PubMed ID: 3596742
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda.
Sampietro M; Piperno A; Lupica L; Arosio C; Vergani A; Corbetta N; Malosio I; Mattioli M; Fracanzani AL; Cappellini MD; Fiorelli G; Fargion S
Hepatology; 1998 Jan; 27(1):181-4. PubMed ID: 9425935
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in porphyria cutanea tarda.
Sampietro M; Fiorelli G; Fargion S
Haematologica; 1999 Mar; 84(3):248-53. PubMed ID: 10189391
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of porphyria cutanea tarda].
Kószó F; Simon M
Orv Hetil; 2000 Apr; 141(14):709-13. PubMed ID: 10803012
[TBL] [Abstract][Full Text] [Related]
17. [Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus].
Wolff C; Stella AM; Armas R; Parraguez A; Silva H; Batlle AM
Rev Med Chil; 1998 Mar; 126(3):245-50. PubMed ID: 9674292
[TBL] [Abstract][Full Text] [Related]
18. The role of iron in the pathogenesis of porphyria cutanea tarda. II. Inhibition of uroporphyrinogen decarboxylase.
Kushner JP; Steinmuller DP; Lee GR
J Clin Invest; 1975 Sep; 56(3):661-7. PubMed ID: 1159079
[TBL] [Abstract][Full Text] [Related]
19. Uroporphyria caused by ethanol in Hfe(-/-) mice as a model for porphyria cutanea tarda.
Sinclair PR; Gorman N; Trask HW; Bement WJ; Szakacs JG; Elder GH; Balestra D; Sinclair JF; Gerhard GS
Hepatology; 2003 Feb; 37(2):351-8. PubMed ID: 12540785
[TBL] [Abstract][Full Text] [Related]
20. Role of inhibition of uroporphyrinogen decarboxylase in PCB-induced porphyria in mice.
Seki Y; Kawanishi S; Sano S
Toxicol Appl Pharmacol; 1987 Aug; 90(1):116-25. PubMed ID: 3114913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
